In this research, although the results had exhibited that the CD133+ liver cancer cell adhesion ability was suppressed after co-cultured with CXCL9 for 24h through binding with CXCR3-A, the mechanism of it was not clarified. This evidence concerns the gene CXCL9 and liver cancer.